These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 34321846)

  • 21. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
    Alkassabany YM; Farghaly AG; El-Ghitany EM
    Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-invasive assessment of hepatic lipid subspecies matched with non-alcoholic fatty liver disease phenotype.
    Erickson ML; Haus JM; Malin SK; Flask CA; McCullough AJ; Kirwan JP
    Nutr Metab Cardiovasc Dis; 2019 Nov; 29(11):1197-1204. PubMed ID: 31371265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.
    Liu X; Chen S; Zhang L
    Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E34-E42. PubMed ID: 32228319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview.
    Marchisello S; Di Pino A; Scicali R; Urbano F; Piro S; Purrello F; Rabuazzo AM
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating lipidomic alterations in obese and non-obese subjects with non-alcoholic fatty liver disease.
    Jung Y; Lee MK; Puri P; Koo BK; Joo SK; Jang SY; Lee DH; Jung YJ; Kim BG; Lee KL; Park TS; Kang KT; Ryu DH; Kang SW; Kim D; Oh S; Kim W; Hwang GS
    Aliment Pharmacol Ther; 2020 Nov; 52(10):1603-1614. PubMed ID: 32892365
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Xu QY; Li H; Cao HX; Pan Q; Fan JG
    Biomed Res Int; 2020; 2020():8869674. PubMed ID: 33294458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stable Isotope-Labeled Lipidomics to Unravel the Heterogeneous Development Lipotoxicity.
    Shih LM; Tang HY; Lynn KS; Huang CY; Ho HY; Cheng ML
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30400243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies.
    Meroni M; Longo M; Dongiovanni P
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31689910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Duodenal-jejunal bypass improves nonalcoholic fatty liver disease independently of weight loss in rodents with diet-induced obesity.
    Angelini G; Castagneto-Gissey L; Casella-Mariolo J; Caristo ME; Russo MF; Lembo E; Verrastro O; Stefanizzi G; Marini PL; Casella G; Bornstein SR; Rubino F; Mingrone G
    Am J Physiol Gastrointest Liver Physiol; 2020 Oct; 319(4):G502-G511. PubMed ID: 32812775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests.
    Masoodi M; Gastaldelli A; Hyötyläinen T; Arretxe E; Alonso C; Gaggini M; Brosnan J; Anstee QM; Millet O; Ortiz P; Mato JM; Dufour JF; Orešič M
    Nat Rev Gastroenterol Hepatol; 2021 Dec; 18(12):835-856. PubMed ID: 34508238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Nonalcoholic Fatty Liver Disease and Weight Loss].
    Ping F; Li YX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Oct; 40(5):597-602. PubMed ID: 30404689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the Lipidomic Signature of Fatty Liver in Children and Adults: A Cross-Sectional Study.
    Mann JP; Jenkins B; Furse S; Snowden SG; Alisi A; Draijer LG; Karnebeek K; Kelly DA; Koot BG; Mosca A; Salvestrini C; van Mourik I; Vreugdenhil A; Zilbauer M; Koulman A;
    J Pediatr Gastroenterol Nutr; 2022 Jun; 74(6):734-741. PubMed ID: 35185113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of hepatic lipid composition in obesity-related metabolic disease.
    Willis SA; Bawden SJ; Malaikah S; Sargeant JA; Stensel DJ; Aithal GP; King JA
    Liver Int; 2021 Dec; 41(12):2819-2835. PubMed ID: 34547171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonalcoholic Fatty Liver Disease: Pathophysiology and Management.
    Carr RM; Oranu A; Khungar V
    Gastroenterol Clin North Am; 2016 Dec; 45(4):639-652. PubMed ID: 27837778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bile acid alterations in nonalcoholic fatty liver disease, obesity, insulin resistance and type 2 diabetes: what do the human studies tell?
    Chávez-Talavera O; Haas J; Grzych G; Tailleux A; Staels B
    Curr Opin Lipidol; 2019 Jun; 30(3):244-254. PubMed ID: 30893108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the Sphingolipidome in NAFLD.
    Montefusco D; Lambert J; Anderson A; Allegood J; Cowart LA
    Methods Mol Biol; 2022; 2455():279-303. PubMed ID: 35213002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic Lipidomics and Molecular Imaging in a Murine Non-Alcoholic Fatty Liver Disease Model: Insights into Molecular Mechanisms.
    Rodríguez-Calvo R; Samino S; Girona J; Martínez-Micaelo N; Ràfols P; García-Altares M; Guaita-Esteruelas S; Junza A; Heras M; Yanes O; Correig X; Masana L
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32899418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?
    Xie C; Halegoua-DeMarzio D
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31752378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
    Asrih M; Jornayvaz FR
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of fibroblast growth factor 21 in the pathogenesis of non-alcoholic fatty liver disease and implications for therapy.
    Liu J; Xu Y; Hu Y; Wang G
    Metabolism; 2015 Mar; 64(3):380-90. PubMed ID: 25516477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.